From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Health Security

Blue Ribbon Study Panel on Biodefense Holds First Meeting

by Global Biodefense Staff
December 8, 2014

The inaugural meeting of the Blue Ribbon Study Panel on Biodefense, a bipartisan panel co-chaired by former Senator Joe Lieberman and former Governor and Homeland Security Secretary Tom Ridge, took place last week on Dec. 4.

Panelists included former Senator Tom Daschle, former Secretary of Health and Human Services Donna Shalala, former US Homeland Security Advisor Kenneth Wainstein, and Biotechnology Industry Organization (BIO) President and CEO and former Representative Jim Greenwood.

The study will be directed by Dr. Robert Kadlec, former Special Assistant to the President for Homeland Security and Senior Director for Biological Defense Policy in the White House Homeland Security Council.

The Panel will identify and recommend changes to U.S. policy and law to strengthen national biodefense and preparedness while optimizing resource investments with the goal of issuing a report in the spring of 2015.

“The efforts of this panel could not be more timely, as our nation continues to face growing challenges and threats from abroad, including infectious diseases such as Ebola and terrorist groups who have voiced a desire to obtain chemical and biological weapons,” said BIO President and CEO Jim Greenwood. “It is clearly necessary to assess our current biodefense capabilities and readiness to respond to such threats.”

From Our Partners

Related Posts

BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster
Preparedness

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs
Health Security

Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs

May 4, 2022
BugSeq Awarded BARDA DRIVe Funding to Develop Next-Gen Diagnostics for Any Respiratory RNA Virus
Health Security

BugSeq Awarded BARDA DRIVe Funding to Develop Next-Gen Diagnostics for Any Respiratory RNA Virus

May 3, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC